Worldwide shipping · 120+ destinationsCOA & GHS SDS with every lotMon–Sat, 09:30–18:30 IST
VAQORACHEMICALS
Pharmacopeial Impurities (EP / USP / BP)Reference StandardAvailable on request

Levodopa EP Impurity C

Synonyms: Levodopa Related Compound B Hydrochloride Salt · 2-Amino-3-(4-hydroxy-3-methoxyphenyl)propanoic acid hydrochloride · 3-O-Methyldopa hydrochloride, DL- · Tyrosine, 3-methoxy-, hydrochloride

CAS No.91013-37-5
FormulaC10H14ClNO4
Mol. weight247.67
Catalogue No.VQ-048868
PurityReference Standard
HSN38229090

Levodopa EP Impurity C (CAS 91013-37-5) – Levodopa impurity standard. C10H14ClNO4, MW 247.67. Buy from Vaqora Chemicals with COA and worldwide shipping.

Pack sizesPrice on quotation · bulk available
10 mg
25 mg
50 mg
100 mg
Bulk / custom pack · kg to MT
Enquire
Enquire
Batch COA with every lot
16-section GHS SDS
Export to 120+ countries
DG-compliant packing

About Levodopa EP Impurity C

Listed under CAS 91013-37-5, Levodopa EP Impurity C is a pharmacopeial impurity of Levodopa available from Vaqora Chemicals. With the molecular formula C10H14ClNO4, it has a molar mass of 247.67 g/mol. Common synonyms include 3-O-Methyldopa hydrochloride, DL- and Tyrosine, 3-methoxy-, hydrochloride.

It is supplied as a solid. Store the standard in its sealed vial, protected from light and moisture, and follow the storage condition printed on the COA. Under GHS it is labelled “Warning”, so handle it with suitable PPE and consult the SDS.

Pharmaceutical QC and development laboratories use this impurity standard of Levodopa to develop and validate HPLC methods, to set specification limits and to document impurity profiles in ANDA and DMF submissions. Our customers for this product work in pharmaceutical manufacturing and academic and industrial research.

Standard pack sizes are 10 mg, 25 mg, 50 mg and 100 mg, and every batch ships with a Certificate of Analysis (COA) and we export worldwide.

Typical applications

  • Pharmacopeial method verification
  • Impurity profiling
  • QC release testing
  • ANDA / DMF filings

Industries

Related to Levodopa

View every impurity, metabolite and intermediate we list for Levodopa.

Levodopa impurities

Grade guides

Specifications & identifiers

Chemical identifiers
Product nameLevodopa EP Impurity C
Catalogue No.VQ-048868
CAS Number91013-37-5
IUPAC name2-amino-3-(4-hydroxy-3-methoxyphenyl)propanoic acid;hydrochloride
Molecular formulaC10H14ClNO4
Molecular weight247.67 g/mol
Exact mass247.0611
GradeReference Standard
HSN code38229090
InChIKeyUNETXNZYVGKTSS-UHFFFAOYSA-N
SMILESCOC1=C(C=CC(=C1)CC(C(=O)O)N)O.Cl
PubChem CID13206353
Physical properties
Physical formSolid
H-bond donors / acceptors4 / 5
TPSA92.8 Ų
SynonymsLevodopa Related Compound B Hydrochloride Salt, 2-Amino-3-(4-hydroxy-3-methoxyphenyl)propanoic acid hydrochloride, 3-O-Methyldopa hydrochloride, DL-, Tyrosine, 3-methoxy-, hydrochloride, 2-Amino-3-(4-hydroxy-3-methoxy-phenyl)-propionic acid hydrochloride, 3-O-Methyl-DL-DOPA (hydrochloride), DL-3-O-methyldopa hydrochloride, 2-Amino-3-(4-hydroxy-3-methoxy-phenyl)-propionic Acid HCl

Safety & hazard information (GHS)

GHS07 Harmful / irritant
Harmful / irritant

Signal word: Warning

Hazard statements

  • H315Causes skin irritation
  • H319Causes serious eye irritation
  • H335May cause respiratory irritation

Precautionary statements: P261, P264, P264 + P265, P271, P280, P302 + P352, P304 + P340, P305 + P351 + P338, P319, P321, P332 + P317, P337 + P317, P362 + P364, P403 + P233, P405, P501

Classification is indicative (aggregated GHS notifications) and may vary by grade and concentration. Always refer to the SDS supplied with your lot.

Documents

Frequently asked questions

What is the CAS number of Levodopa EP Impurity C?

The CAS Registry Number of Levodopa EP Impurity C is 91013-37-5. It is also known as Levodopa Related Compound B Hydrochloride Salt, 2-Amino-3-(4-hydroxy-3-methoxyphenyl)propanoic acid hydrochloride, 3-O-Methyldopa hydrochloride, DL-.

What is the molecular formula and molecular weight of Levodopa EP Impurity C?

Levodopa EP Impurity C has the molecular formula C10H14ClNO4 and a molecular weight of 247.67 g/mol.

What is Levodopa EP Impurity C used for?

Levodopa EP Impurity C is supplied as a characterised reference material related to Levodopa. It is used for analytical method development and validation (AMV), impurity profiling, stability studies and quality control, and in ANDA/DMF regulatory filings.

Which grade and pack sizes of Levodopa EP Impurity C can I order?

We supply Levodopa EP Impurity C in Reference Standard grade, in 10 mg, 25 mg, 50 mg, 100 mg packs. Larger bulk quantities and custom packing are quoted on request.

Do you provide a COA and SDS with Levodopa EP Impurity C?

Yes. Every lot of Levodopa EP Impurity C is shipped with a batch-specific Certificate of Analysis, and a 16-section GHS Safety Data Sheet is provided with the quotation and the shipment.

Can Levodopa EP Impurity C be shipped internationally?

Yes. Levodopa EP Impurity C is classified as hazardous, so it is packed in UN-approved packaging and shipped as dangerous goods under IATA/IMDG rules. We export worldwide on EXW, FOB, CIF and DAP terms.

Enquire about Levodopa EP Impurity C

We reply within one business day with price, pack options, lead time and documentation.

By submitting you agree to our privacy policy. We never share your details.

Why buyers choose Vaqora

  • Batch-traceable lots with COA
  • R&D packs to multi-tonne supply
  • IATA / IMDG dangerous-goods packing
  • EXW, FOB, CIF, DAP Incoterms
  • Custom synthesis & sourcing
How ordering works

Related products

Reference Standard
Etilevodopa chemical structure
Etilevodopa
CAS
37178-37-3
Formula
C11H15NO4
MW
225.24 g/mol
VQ-048869
Reference Standard
3-O-Methyldopa-d3 chemical structure
3-O-Methyldopa-d3
CAS
586954-09-8
Formula
C10H13NO4
MW
214.23 g/mol
VQ-041152
Reference Standard
Dopaquinone chemical structure
Dopaquinone
CAS
25520-73-4
Formula
C9H9NO4
MW
195.17 g/mol
VQ-039706
Reference Standard
Levodopa-d3 chemical structure
Levodopa-d3
CAS
53587-29-4
Formula
C9H11NO4
MW
200.21 g/mol
VQ-038002

More in Pharmacopeial Impurities (EP / USP / BP) →